Greenwich LifeSciences, Inc. Quarterly Debt-to-equity in % from Q2 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Greenwich LifeSciences, Inc. quarterly Debt-to-equity history and growth rate from Q2 2021 to Q3 2024.
  • Greenwich LifeSciences, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 12.7 %, a 414% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 12.7 +10.2 +414% Sep 30, 2024
Q2 2024 8.79 +6.76 +332% Jun 30, 2024
Q1 2024 4.1 +2.41 +143% Mar 31, 2024
Q4 2023 2.98 +1.49 +99.9% Dec 31, 2023
Q3 2023 2.47 +1.08 +77.8% Sep 30, 2023
Q2 2023 2.04 +0.61 +42.7% Jun 30, 2023
Q1 2023 1.69 +0.02 +1.2% Mar 31, 2023
Q4 2022 1.49 -0.41 -21.6% Dec 31, 2022
Q3 2022 1.39 -1.07 -43.5% Sep 30, 2022
Q2 2022 1.43 -2.94 -67.2% Jun 30, 2022
Q1 2022 1.67 Mar 31, 2022
Q4 2021 1.9 Dec 31, 2021
Q3 2021 2.46 Sep 30, 2021
Q2 2021 4.37 Jun 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.